Man Group PLC Boston Scientific Corp Transaction History

Man Group PLC

$37.2 Billion
Q1 2025

A detailed history of Man Group PLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Man Group PLC holds 828,732 shares of BSX stock, worth $85.2 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

828,732

Previous 271,059 205.74%

Holding current value

$85.2 Million

Previous $24.2 Million 245.32%

% of portfolio

0.22%

Previous 0.07%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$89.38 - $106.18 $49.8 Million - $59.2 Million	557,673 Added 205.74%	828,732 $83.6 Million
Q4 2024 Feb 14, 2025	BUY	$83.62 - $91.5 $5.24 Million - $5.73 Million	62,662 Added 30.07%	271,059 $24.2 Million
Q3 2024 Nov 14, 2024	BUY	$72.96 - $84.0 $4.58 Million - $5.27 Million	62,766 Added 43.1%	208,397 $17.5 Million
Q2 2024 Aug 14, 2024	SELL	$67.33 - $77.71 $3.49 Million - $4.03 Million	-51,870 Reduced 26.26%	145,631 $11.2 Million
Q1 2024 May 15, 2024	BUY	$57.6 - $68.62 $174,470 - $207,849	3,029 Added 1.56%	197,501 $13.5 Million
Q4 2023 Feb 14, 2024	SELL	$48.64 - $57.81 $7.92 Million - $9.41 Million	-162,776 Reduced 45.56%	194,472 $11.2 Million
Q3 2023 Nov 14, 2023	SELL	$50.19 - $54.68 $337,979 - $368,215	-6,734 Reduced 1.85%	357,248 $18.9 Million
Q2 2023 Aug 14, 2023	BUY	$49.72 - $54.64 $14.8 Million - $16.2 Million	296,900 Added 442.59%	363,982 $19.7 Million
Q1 2023 May 15, 2023	SELL	$45.09 - $50.03 $3.48 Million - $3.86 Million	-77,215 Reduced 53.51%	67,082 $3.36 Million
Q4 2022 Feb 14, 2023	BUY	$39.56 - $47.22 $5.71 Million - $6.81 Million	144,297 New	144,297 $6.68 Million
Q2 2022 Aug 15, 2022	SELL	$35.24 - $47.1 $3.72 Million - $4.97 Million	-105,516 Reduced 85.32%	18,150 $677,000
Q1 2022 May 16, 2022	SELL	$40.9 - $45.1 $15.6 Million - $17.2 Million	-381,056 Reduced 75.5%	123,666 $5.48 Million
Q4 2021 Feb 14, 2022	SELL	$38.07 - $44.87 $25.2 Million - $29.7 Million	-661,696 Reduced 56.73%	504,722 $21.4 Million
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $9.77 Million - $10.9 Million	-236,882 Reduced 16.88%	1,166,418 $50.6 Million
Q2 2021 Aug 16, 2021	BUY	$38.58 - $44.24 $46.9 Million - $53.7 Million	1,214,482 Added 643.2%	1,403,300 $60 Million
Q1 2021 May 17, 2021	SELL	$35.27 - $39.67 $16 Million - $18 Million	-453,319 Reduced 70.6%	188,818 $7.3 Million
Q4 2020 Feb 16, 2021	BUY	$33.15 - $41.97 $10 Million - $12.7 Million	302,778 Added 89.22%	642,137 $23.1 Million
Q3 2020 Nov 16, 2020	BUY	$34.44 - $42.23 $10.1 Million - $12.4 Million	293,587 Added 641.41%	339,359 $13 Million
Q2 2020 Aug 14, 2020	SELL	$30.19 - $39.11 $1.45 Million - $1.88 Million	-48,042 Reduced 51.21%	45,772 $1.61 Million
Q1 2020 May 15, 2020	SELL	$25.83 - $45.71 $3.46 Million - $6.12 Million	-133,852 Reduced 58.79%	93,814 $3.06 Million
Q4 2019 Feb 18, 2020	BUY	$37.87 - $45.37 $5.31 Million - $6.36 Million	140,182 Added 160.24%	227,666 $10.3 Million
Q3 2019 Nov 14, 2019	SELL	$40.31 - $43.45 $2.16 Million - $2.33 Million	-53,637 Reduced 38.01%	87,484 $3.56 Million
Q2 2019 Aug 14, 2019	SELL	$34.91 - $42.98 $5.66 Million - $6.97 Million	-162,165 Reduced 53.47%	141,121 $6.07 Million
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $606,070 - $750,452	18,416 Added 6.46%	303,286 $11.6 Million
Q4 2018 Feb 14, 2019	SELL	$31.73 - $39.04 $15.6 Million - $19.2 Million	-490,583 Reduced 63.26%	284,870 $10.1 Million
Q3 2018 Nov 14, 2018	SELL	$32.83 - $38.63 $15.9 Million - $18.7 Million	-483,565 Reduced 38.41%	775,453 $29.9 Million
Q2 2018 Aug 14, 2018	BUY	$26.84 - $34.32 $24 Million - $30.7 Million	895,617 Added 246.45%	1,259,018 $41.2 Million
Q1 2018 May 15, 2018	BUY	$25.2 - $28.54 $9.16 Million - $10.4 Million	363,401 New	363,401 $9.93 Million

Others Institutions Holding BSX

# of Institutions

1,831

Shares Held

1.21B

Call Options Held

9.66M

Put Options Held

6.98M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $147B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account